Ver en grande 
Pirtobrutinib (LOXO-305)
AM-M10604-50mg
Producto nuevo
Pirtobrutinib (LOXO-305; LY 3527727; RXC-005) is a first-in-class, highly selective, non-covalent, next-generation BTK inhibitor with an IC50 of 5.69 nM in WT BTK HEK cells.Pirtobrutinib's selectivity for BTK more than 300 times more selective than other 370 kinases. Pirtobrutinib can be used in studies related to chronic lymphocytic leukemia (CLL).
Al comprar este producto puede obtener hasta 55 puntos de fidelidad. Su cesta totalizará 55 puntos de fidelidad que se puede(n) transformar en un cupón de descuento de 11.00EUR.
Ficha de datos
| Size | 50mg |
| Storage Conditions | 2-8°C, sealed |
| Molecular Weight | C22H21F4N5O3 |
| Research Area | BTK |
| CAS Number | '2101700-15-4 |
| Smiles | COC1=CC=C(F)C=C1C(=O)NCC2=CC=C(C=C2)C3=N[N](C(C)C(F)(F)F)C(=C3C(N)=O)N |